Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIMSON phase II trial of add-on high-dose simvastatin in multiple sclerosis patients on ocrelizumab or natalizumab
2019-003127-38Phase 2Active
- Sponsor
- Amsterdam UMC, location VUmc
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of simvastatin in multiple sclerosis (MS) (2 arms), sponsored by Amsterdam UMC, location VUmc. Primary endpoint: Change in whole brain atrophy rate. Started Apr 2020; status: active.
02
Drugs
simvastatin
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2019-003127-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003127-38.